Publications

GPC2 MAY BE AN IMMUNOTHERAPEUTIC TARGET IN HIGH-RISK NEUROBLASTOMA

AMER ASSOC CANCER RESEARCH

September 22, 2017
Bosse, KR, P Raman, Z Zhu, M Lane, D Martinez, and S Heitzeneder

Summary